SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide

The study titled “SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide” provides groundbreaking insights into the potential link between COVID-19 and neurodegenerative diseases (NDs). Here’s a detailed summary: Background and Objectives: Methodology: Key Findings: Discussion and Implications: In conclusion, this study sheds new light on the potential role of SARS-CoV-2 spike protein in accelerating amyloid formation related to neurodegenerative diseases, offering a novel avenue for understanding and potentially intervening in the progression of these conditions. Read More: https://www.biorxiv.org/content/10.1101/2023.09.01.555834v1.abstract

Unveiling the Connection Between COVID-19 and New-Onset Alzheimer’s Disease

A groundbreaking study published in the Journal of Alzheimer’s Disease has shed light on the potential link between COVID-19 and the increased risk of developing Alzheimer’s disease. Here’s a detailed look at the findings: Overview of the Study Key Findings Discussion and Implications Conclusion This study presents compelling evidence linking COVID-19 with an increased risk of developing Alzheimer’s disease, particularly among older adults. As the world continues to grapple with the long-term effects of the COVID-19 pandemic, these findings underscore the importance of monitoring and addressing the cognitive health impacts in COVID-19 survivors. Read More: https://eswi.org/cnt/article/association-covid-19-new-onset-alzheimers-disease-364